Real-World Evidence of Patient Outcome Following GIST Treatment with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland
Real-World Evidence of Patient Outcome Following GIST Treatment with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland
prof. Marcin Czech, Melania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Burylo, Joanna Polowinczak-Przybylek, Piotr Potemski, Andrzej Sliwczynski >> pobierz artykuł
